Partial Vaccine May Be Available Now
#11
It's starting to look more likely that the Rubella component of the MMR vaccine has a very high correlation to low severity in COVID cases. The other components may help as well. This hypothesis, made by two individuals, has been discussed here before but now has preliminary verification by heavy-hitter research organizations.
Hasn't hit big mainstream media yet, but these sources appear reputable:
https://www.globenewswire.com/news-r...anization.html
https://kdwn.com/2020/04/24/mmr-vacc...-for-covid-19/
https://www.medrxiv.org/content/10.1....10.20053207v1
And in 2014 researchers concluded that the measles vaccine protected against SARS (aka COVID-01).
https://www.sciencedirect.com/scienc...42682214000051
Verification of this, and ramping up production can be accomplished more quickly than certifying a new vaccine... and much of the population is already vaccinated anyway.
If this pans out, it will become the definitive case study of "Better to be Lucky than Good".
Hasn't hit big mainstream media yet, but these sources appear reputable:
https://www.globenewswire.com/news-r...anization.html
https://kdwn.com/2020/04/24/mmr-vacc...-for-covid-19/
https://www.medrxiv.org/content/10.1....10.20053207v1
And in 2014 researchers concluded that the measles vaccine protected against SARS (aka COVID-01).
https://www.sciencedirect.com/scienc...42682214000051
Verification of this, and ramping up production can be accomplished more quickly than certifying a new vaccine... and much of the population is already vaccinated anyway.
If this pans out, it will become the definitive case study of "Better to be Lucky than Good".
#12
Prime Minister/Moderator
Thread Starter
Joined APC: Jan 2006
Position: Engines Turn Or People Swim
Posts: 39,252
I think the real question is if anyone is going to really study it or is it more profitable for the Pharma companies to make a new vaccine? The real research has been done by a Statistician and a Veterinarian backed up with a little research from Cambridge. That's probably scaring off everyone!
The people who make the MMR vaccine would probably get behind further analysis.
Also this does not look like it would replace a COVID vax, just that it could reduce severity and deaths.
#13
Agreed. I would like to think this is good research but even if it’s bad, damn it’s presented well. About now if you told the American people that if you get a booster, you will get sick but not die, they would be lining up to get a semblance of normal back.
#14
Banned
Joined APC: Feb 2020
Position: Gummed
Posts: 1,060
RNA bugs are not "treatable" from vaccine standpoint. See HIV, SARs etc. However, mitigation like you've mentioned is always promising and certainly helps. Thanks for posting up the research. It was a good read.
#15
:-)
Joined APC: Feb 2007
Posts: 7,339
The vaccine situation with Covid is going to be another political crisis, because it's probably only going to be available in limited quantities, and extremely expensive.
#16
Prime Minister/Moderator
Thread Starter
Joined APC: Jan 2006
Position: Engines Turn Or People Swim
Posts: 39,252
$5K/dose * 330M people in the US = $1.65T
We're already into it for more than that.
#17
Gets Weekends Off
Joined APC: Sep 2014
Posts: 824
#19
:-)
Joined APC: Feb 2007
Posts: 7,339
Moderna is probably going to be the first company to have the vaccine, to shorten the development time scale, they are creating a prototype manufacturing process in parallel with their vaccine trials. If they are successful, there is only one company that has this production technology. It will take years to ramp up production for the rest of the world. So for the first couple years, the vaccine will be for Americans only.
#20
Gets Weekends Off
Joined APC: Oct 2018
Posts: 564
Moderna has formally started phase 2 studies of their vaccine. This is a modified phase 2 study.
Usually phase 2 studies measure safety, along with some efficacy and is split into two seperate studies. Instead special exemption was approved and phase 2 a and 2 b studies along with large scales phase 3 studies will be grouped together. This is unprecedented but needed ofcourse. Fingers crossed.
Pfizer has begun phase 1 in human trials this week as well of their innovative vaccine.
Fingers crossed.
Usually phase 2 studies measure safety, along with some efficacy and is split into two seperate studies. Instead special exemption was approved and phase 2 a and 2 b studies along with large scales phase 3 studies will be grouped together. This is unprecedented but needed ofcourse. Fingers crossed.
Pfizer has begun phase 1 in human trials this week as well of their innovative vaccine.
Fingers crossed.
Thread
Thread Starter
Forum
Replies
Last Post